Vantage logo

GSK’s tribulations continue

Two days ago GSK canned lete-cel. Now it is ditching otilimab, and daprodustat’s future is looking dicey.

Vantage logo

Unpacking Royalty Pharma

The serial acquirer of royalty interests is coming into its own, but the secret to its success lies in cystic fibrosis.